|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/19/2024 |
$14.17 |
$14.69 |
$14.05 |
$14.67 |
394.30K | 04/22/2024 |
$14.79 |
$15.13 |
$14.58 |
$14.58 |
611.40K | 04/23/2024 |
$14.57 |
$15.20 |
$14.56 |
$14.67 |
426.40K | 04/24/2024 |
$14.70 |
$14.85 |
$14.57 |
$14.62 |
401.80K | 04/25/2024 |
$14.43 |
$14.85 |
$14.00 |
$14.18 |
527.00K |
|
Deciphera Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing medicines to improve the lives of people with cancer. Using its proprietary switch-control kinase inhibitor platform and capabilities in kinase biology, Co. designs kinase inhibitors to target the switch pocket region of the kinase with the goal of developing medicines. QINLOCK, Co.'s switch-control kinase inhibitor, was developed using Co.'s proprietary drug discovery platform and developed for the treatment of fourth-line gastrointestinal stromal tumor. Co. has developed a pipeline of drug candidates, including vimseltinib and DCC-3116. | |
|
Deciphera Pharmaceuticals (DCPH) has the following price history information. Looking back at DCPH historical stock prices for the last five trading days, on April 19, 2024, DCPH opened at $14.17, traded as high as $14.69 and as low as $14.05, and closed at $14.67. Trading volume was a total of 394.30K shares. On April 22, 2024, DCPH opened at $14.79, traded as high as $15.13 and as low as $14.58, and closed at $14.58. Trading volume was a total of 611.40K shares. On April 23, 2024, DCPH opened at $14.57, traded as high as $15.20 and as low as $14.56, and closed at $14.67. Trading volume was a total of 426.40K shares. On April 24, 2024, DCPH opened at $14.70, traded as high as $14.85 and as low as $14.57, and closed at $14.62. Trading volume was a total of 401.80K shares. On April 25, 2024, DCPH opened at $14.43, traded as high as $14.85 and as low as $14.00, and closed at $14.18. Trading volume was a total of 527.00K shares.
DCPH Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Deciphera Pharmaceuticals shares, starting with a $10,000 purchase of DCPH, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
09/29/2017 |
|
End date: |
04/25/2024 |
|
Start price/share: |
$18.99 |
|
End price/share: |
$14.18 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-25.33% |
|
Average Annual Total Return: |
-4.34% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$7,469.57 |
|
Years: |
6.58 |
|
|
|
Date |
Close |
04/19/2024 | $14.67 | 04/22/2024 | $14.58 | 04/23/2024 | $14.67 | 04/24/2024 | $14.62 | 04/25/2024 | $14.18 |
|
|